Among women undergoing ovarian stimulation in antagonist protocols, combined oral contraceptive pill (COCP) pretreatment was associated with a lower rate of live birth or ongoing pregnancy than no pretreatment, according to a Cochrane review of 29 randomized controlled trials (RCTs) of hormonal pretreatment in 4,701 women undergoing assisted reproductive technology (ART). The review determined whether pretreatment with the COCP or with a progestogen or estrogen alone in ovarian stimulation protocols affects outcomes in subfertile couples undergoing ART. Findings included:
- COCP pretreatment was associated with a lower rate of live birth or ongoing pregnancy vs no pretreatment.
- There was insufficient evidence to determine whether rates of live birth or ongoing pregnancy were influenced by pretreatment with progestogens or estrogens, or by COCP pretreatment using other stimulation protocols.
- Overall, findings of adverse events were inconclusive, except that progesterone pretreatment may reduce the risk of ovarian cysts in agonist cycles, and COCP in antagonist cycles may reduce the risk of pregnancy loss vs no pretreatment.
Farquhar C, Rombauts L, Kremer JAM, Lethaby A, Ayeleke RO. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. Cochrane Database of Systematic Reviews. 2017, Issue 5. Art. No.:CD006109. doi:10.1002/14651858.CD006109.pub3.
This Week's Must Reads
Must Reads in Contraception
Bleeding and Spotting with the LNG 13.5 mg IUS, Contraception; ePub 2019 Mar 1; Shimoni, et al
Contraception and Chronic Opioid Prescriptions, Contraception; ePub 2019 Feb 11; Ray-Griffith, et al
Hormonal Contraception & Coexisting Medical Conditions, Obstet Gynecol; ePub 2019 Feb; Allen, et al
Contraceptive Switching & Discontinuation, Am J Obstet Gynecol; ePub 2018 Dec 18; Simmons, et al
Efficacy of a Levonorgestrel 52-mg IU System, Obstet Gynecol; ePub 2018 Dec 4; Teal, et al